PSNC Briefing 050/21: Regulatory amendments in late 2021/early 2022
Published on: 21st December 2021 | Updated on: 10th June 2022
This briefing provides information about the regulatory amendments due to be introduced in late 2021/early 2022. These regulatory changes introduce a range of new measures, including a new type of pharmaceutical service, the National Enhanced Service, various pandemic related changes and previously indicated changes related to Pharmaceutical Needs Assessments (PNAs); as well as a change to the market entry regulations.
For more information on this topic please email email@example.com